Related Experiment Videos
[Photodynamic therapy for multiple primary lung cancer]
C Konaka1, T Okunaka, K Furukawa
1Dept. of Surgery, Tokyo Medical College.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|January 1, 1996
Summary
Photodynamic therapy (PDT) offers a lung-sparing treatment for multiple primary lung cancers, improving survival rates. This approach is particularly beneficial for central lung cancers, preserving pulmonary function.
Area of Science:
- Pulmonology
- Oncology
- Medical Technology
Context:
- Multiple primary lung cancers are increasingly diagnosed due to advances in detection and treatment.
- Surgical resection of all lesions in multiple primary lung cancer can be challenging due to pulmonary function limitations.
Purpose:
- To evaluate the efficacy of photodynamic therapy (PDT) in treating multiple primary lung cancers.
- To assess PDT's role in preserving lung function and improving patient prognosis.
Summary:
- Photodynamic therapy (PDT) was used to treat 27 patients with multiple primary lung cancers between 1980 and the study period.
- 14 patients had synchronous cancers, while 13 had metachronous ones.
- PDT alone treated early-stage lesions in 7 patients; combined with surgery, it addressed advanced lesions in 20 patients.
Impact:
- PDT demonstrated a mean survival of 52 months, with 16 patients alive at the time of reporting.
- PDT expands therapeutic options and improves outcomes for patients with multiple primary bronchogenic carcinomas.
- This modality is especially effective for central lung cancers, aiding in lung function preservation.